TP53 and lung cancer: p53 mutation is a common phenomenon in lung cancer and linked to decreased survival in patients receiving cisplatin-based chemotherapy [48], TP53 mutational spectrum in human cancers has shown the R175H mutation occurs most frequently with an overall frequency of 4.6% [49].